title: Arterial and venous thrombosis in endocrine diseases.
abstract: Endocrine diseases have been associated with cardiovascular events. Both altered coagulation and fibrinolysis markers and thrombotic disorders have been described in several endocrine diseases. This review summarizes the evidence on the influence of thyroid diseases, cortisol excess and deficiency, pheochromocytoma, hyperparathyroidism, hyperaldosteronism, hyperprolactinemia, and growth hormone excess and deficiency; on parameters of hemostasis; and on arterial and venous thrombotic events. All these endocrine diseases do have, or may have, influence either on hemostasis or on the risk of thrombotic events. Future studies are needed to establish the clinical relevance of these associations.
authors: Department of Internal Medicine, Slotervaartziekenhuis, Amsterdam, The Netherlands.
authors: Bregje
authors: B
authors: van Zaane
authors: Danka J F
authors: DJ
authors: Stuijver
authors: Alessandro
authors: A
authors: Squizzato
authors: Victor E A
authors: VE
authors: Gerdes
mesh_terms: D001157:Arterial Occlusive Diseases / Q000150:complications*; D004700:Endocrine System Diseases / Q000150:complications*; D013006:Growth Hormone / Q000172:deficiency / Q000378:metabolism; D006487:Hemostasis; D006801:Humans; D006854:Hydrocortisone / Q000172:deficiency / Q000378:metabolism; D013927:Thrombosis / Q000150:complications*; D013959:Thyroid Diseases / Q000150:complications; D020246:Venous Thrombosis / Q000150:complications*
chemical_list: D013006:Growth Hormone; D006854:Hydrocortisone